Natural compound targeting metabolism: A new insight for the treatment of triple negative breast cancer

被引：0
|
作者：
Arora, Ritu [1 ]
Schmitt, David [1 ]
McClellan, Steve [1 ]
Tan, Ming [1 ]
Dean-Colomb, Windy [1 ]
机构：
[1] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3370
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3370
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Enzalutamide: A new hormonal treatment for triple-negative breast cancer?
    Caiazza, Francesco
    Murray, Alyson
    Madden, Stephen F.
    Synnott, Naoise C.
    O'Donovan, Norma
    Crown, John
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
    El Hejjioui, Brahim
    Lamrabet, Salma
    Joutei, Sarah Amrani
    Senhaji, Nadia
    Bouhafa, Touria
    Malhouf, Moulay Abdelilah
    Bennis, Sanae
    Bouguenouch, Laila
    DIAGNOSTICS, 2023, 13 (11)
  • [33] Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach
    Rajamanickam, Subapriya
    Park, Jun Hyoung
    Bates, Kaitlyn
    Timilsina, Santosh
    Eedunuri, Vijay Kumar
    Onyeagucha, Benjamin
    Subbarayalu, Panneerdoss
    Abdelfattah, Nourhan
    Jung, Kwang Hwa
    Favours, Edward
    Mohammad, Tabrez A.
    Chen, Hung-I Harry
    Vadlamudi, Ratna K.
    Chen, Yidong
    Kaipparettu, Benny A.
    Arbiser, Jack L.
    Rao, Manjeet K.
    CANCER RESEARCH, 2018, 78 (04)
  • [34] Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
    Das, Sonia G.
    Pianetti, Stefania
    Sonenshein, Gail E.
    Mineva, Nora D.
    CANCER RESEARCH, 2017, 77
  • [35] Targeting LIFR enhances the activity of HDAC inhibitors for the treatment of triple negative breast cancer
    Viswanadhapalli, Suryavathi
    Li, Mengxing
    Santhamma, Bindu
    Pratap, Uday P.
    Luo, Yiliao
    Liu, Junhao
    Altwegg, Kristin A.
    Li, Xiaonan
    Yan, Hui
    Xu, Zhenming
    Brenner, Andrew
    Sareddy, Gangadhara R.
    Tekmal, Rajeshwar R.
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2020, 80 (04)
  • [36] Innovative Nanomaterials for Targeting Hypoxia to Improve Treatment for Triple-negative Breast Cancer
    Ray S.K.
    Mukherjee S.
    Recent Patents on Biotechnology, 2024, 18 (04) : 269 - 272
  • [37] Immunotherapy Treatment for Triple Negative Breast Cancer
    Berger, Elizabeth R.
    Park, Tristen
    Saridakis, Angeleke
    Golshan, Mehra
    Greenup, Rachel A.
    Ahuja, Nita
    PHARMACEUTICALS, 2021, 14 (08)
  • [38] Treatment Progress in Triple Negative Breast Cancer
    Kraemer, Stefan
    Rogmans, Christoph
    Saylan, Dilek
    Friedrich, Dominique
    Kraft, Clayton
    Rogmans, Gunther
    Wirtz, Marina
    Friedrich, Michael
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (02) : 341 - 352
  • [39] Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer Cells
    Alneyadi, Aysha
    Nizami, Zohra Nausheen
    Aburawi, Hanan E. E.
    Hisaindee, Soleiman
    Nawaz, Muhammad
    Attoub, Samir
    Ramadan, Gaber
    Benhalilou, Nehla
    Al Azzani, Mazoun
    Elmahi, Yassine
    Almeqbali, Aysha
    Muhammad, Khalid
    Eid, Ali H. H.
    Vijayan, Ranjit
    Iratni, Rabah
    CANCERS, 2023, 15 (10)
  • [40] Targeting glutamine metabolism inhibits GD2+breast cancer stem cell function in triple negative breast cancer
    Ly, Stanley
    Nguyen, Khoa
    Andreeff, Michael
    Battula, Venkata Lokesh
    CANCER RESEARCH, 2020, 80 (04)
12345